| Serial Number | 76122113 |
| Word Mark | EPIGENEXPRESS |
| Filing Date | Wednesday, August 23, 2000 |
| Status | 604 - ABANDONED - AFTER INTER-PARTES DECISION |
| Status Date | Thursday, December 18, 2003 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 22, 2002 |
| Goods and Services | Medical in vitro diagnostic preparations for Target Validation in the fields of respiratory, cardiovascular, immune, central nervous system and endocrine ailments, for therapeutic and diagnostic purposes, for medical use, including for treatment of human and non-human animal respiratory, central nervous system, immune, endocrine, cardiovascular and neoplastic ailments, including bronchoconstriction, anxiety, Pre Menstrual Syndrome, Menopause symptoms, anxiety, lack of sleep, mental unrest eg resulting from in-take of steroids, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms, medical diagnostic reagents for testing, preventing and therapeutically treating immune, central nervous system, endocrine, neoplastic, cardiovascular, respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as all metastatic cancers, eg cancers which metastasized to the lung(s), breast, liver and prostate |
| Pseudo Mark | EPIGENE EXPRESS |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Friday, December 19, 2003 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, May 31, 1996 |
| First Use In Commerce Date | Friday, May 31, 1996 |
| Party Name | EPIGENESIS Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cranbury, NJ 08512 |
| Party Name | EPIGENESIS Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cranbury, NJ 08512 |
| Event Date | Event Description |
| Thursday, December 18, 2003 | ABANDONMENT - AFTER INTER PARTES DECISION |
| Thursday, December 18, 2003 | OPPOSITION TERMINATED NO. 999999 |
| Thursday, December 18, 2003 | OPPOSITION TERMINATED NO. 999999 |
| Thursday, December 18, 2003 | OPPOSITION SUSTAINED NO. 999999 |
| Thursday, March 13, 2003 | OPPOSITION INSTITUTED NO. 999999 |
| Wednesday, December 4, 2002 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, October 22, 2002 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 2, 2002 | NOTICE OF PUBLICATION |
| Thursday, August 1, 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, March 5, 2002 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 7, 2001 | FINAL REFUSAL MAILED |
| Friday, August 10, 2001 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 7, 2001 | NON-FINAL ACTION MAILED |
| Wednesday, January 24, 2001 | ASSIGNED TO EXAMINER |
| Wednesday, January 24, 2001 | ASSIGNED TO EXAMINER |
| Tuesday, January 23, 2001 | ASSIGNED TO EXAMINER |